Drug Formulation with Cyclodextrins
Velesco is a niche contract research organization (CRO) specializing in early phase drug development. One of our core competencies is formulation of compounds for early toxicology studies. We take a targeted, scientific approach to pharmaceutical formulation.
One of our tools for formulation of poorly soluble early stage compounds is the family of cyclodextrins.
To learn more about how Velesco is utilizing cyclodextrins in early phase drug development, download our free whitepaper describing cyclodextrins and how they can be used as early stage solubilizers.
News and Events
New job posting! Careers
Velesco has been awarded a subcontract for analytical method development, manufacturing clinical supplies, and testing the stability of an investigational drug for the treatment of Beta-Thalassemia through the NCATS! Read the press release here.
We are celebrating our 10th anniversary in 2017!
Velesco's work published in
a Drug Development & Delivery article!
Read it here.
Dave Barnes Featured in